Haematological Disease
Patients with haematological diseases are major users of blood components. This chapter focuses on bone marrow failure syndromes and stem cell transplantation, in addition to haematological malignancies. The transfusion support of patients with haematological disease may be complex and includes the...
| 主要な著者: | , , |
|---|---|
| フォーマット: | Book section |
| 出版事項: |
John Wiley and Sons
2013
|
| _version_ | 1826307335106068480 |
|---|---|
| author | Estcourt, L Stanworth, S Stanworth, S Murphy, M Murphy, M |
| author_facet | Estcourt, L Stanworth, S Stanworth, S Murphy, M Murphy, M |
| author_sort | Estcourt, L |
| collection | OXFORD |
| description | Patients with haematological diseases are major users of blood components. This chapter focuses on bone marrow failure syndromes and stem cell transplantation, in addition to haematological malignancies. The transfusion support of patients with haematological disease may be complex and includes the management of ABO mismatched stem cell transplants, the investigation and management of patients who become refractory to platelets and the use of irradiated and CMV-safe blood components. This edition first published 2013 © 2001, 2005, 2009, 2013 John Wiley and Sons Ltd. |
| first_indexed | 2024-03-07T07:01:40Z |
| format | Book section |
| id | oxford-uuid:bb8cde37-3c21-4216-afdb-02ffff40ef72 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T07:01:40Z |
| publishDate | 2013 |
| publisher | John Wiley and Sons |
| record_format | dspace |
| spelling | oxford-uuid:bb8cde37-3c21-4216-afdb-02ffff40ef722022-03-29T17:19:00ZHaematological DiseaseBook sectionhttp://purl.org/coar/resource_type/c_3248uuid:bb8cde37-3c21-4216-afdb-02ffff40ef72Symplectic Elements at OxfordJohn Wiley and Sons2013Estcourt, LStanworth, SStanworth, SMurphy, MMurphy, MPatients with haematological diseases are major users of blood components. This chapter focuses on bone marrow failure syndromes and stem cell transplantation, in addition to haematological malignancies. The transfusion support of patients with haematological disease may be complex and includes the management of ABO mismatched stem cell transplants, the investigation and management of patients who become refractory to platelets and the use of irradiated and CMV-safe blood components. This edition first published 2013 © 2001, 2005, 2009, 2013 John Wiley and Sons Ltd. |
| spellingShingle | Estcourt, L Stanworth, S Stanworth, S Murphy, M Murphy, M Haematological Disease |
| title | Haematological Disease |
| title_full | Haematological Disease |
| title_fullStr | Haematological Disease |
| title_full_unstemmed | Haematological Disease |
| title_short | Haematological Disease |
| title_sort | haematological disease |
| work_keys_str_mv | AT estcourtl haematologicaldisease AT stanworths haematologicaldisease AT stanworths haematologicaldisease AT murphym haematologicaldisease AT murphym haematologicaldisease |